1772-Stimulated Protein Degradation for Mitochondrial
From Paper Talk · 00:24:58
Show by 淼淼Elva
The research discusses stimulated protein degradation as an innovative therapeutic strategy to tackle complex medical conditions characterized by pervasive protein dysregulation, such as neurodegenerative diseases. By utilizing small-molecule agonists to selectively dislodge inhibitory proteins from the stress-responsive E3 ubiquitin ligase CUL2 FEM1B, researchers can activate the enzyme without disrupting its normal substrate recognition. This targeted displacement successfully promotes mitochondrial function and enhances electron transport chain activity by degrading multiple physiological targets simultaneously. Consequently, this pharmacological approach restores neuronal survival in cellular models of conditions like Friedreich’s ataxia and COX deficiency syndrome. Ultimately, this methodology expands the clinical utility of induced protein degradation beyond traditional targeted applications to encompass complex pathologies previously lacking effective treatments.References:Chandrasekhar S, McMinimy R, Manford A G, et al. Stimulated protein degradation to promote mitochondrial function and neuronal survival[J]. Science, 2026, 394(6823): eaed2525.前往小宇宙评论区与主播互动
More episodes
- 1775-In-Cell Structures of Human Pre-Ribosome Assembly
- 1776-CRISPR Mutagenesis of the MYC Locus
- 1777-Menopause and Alzheimer’s Disease Risk
- 1773-Spatial Coordination in Human Urogenital Organogenesis
- 1774-Whole-Body Single-Cell Atlas of Danionella cerebrum
- 1770-Programmable Design of Functional Proteins
- 1771-Clostridium perfringens Delta Toxin Drives Brain Injury
- 1769-Synthetic RNA Transfer Vehicles
- 1768-Spatial CRISPR Screening for Complex Phenotypes
- 1766-Human Microglial Plasticity in Aging and Alzheimer's
PodSearch is a free, independent podcast search engine. Read about PodSearch, the privacy policy or contact us.